JPH06510208A - 多量体形態のヒトライノウイルスレセプタ蛋白質 - Google Patents

多量体形態のヒトライノウイルスレセプタ蛋白質

Info

Publication number
JPH06510208A
JPH06510208A JP6502541A JP50254194A JPH06510208A JP H06510208 A JPH06510208 A JP H06510208A JP 6502541 A JP6502541 A JP 6502541A JP 50254194 A JP50254194 A JP 50254194A JP H06510208 A JPH06510208 A JP H06510208A
Authority
JP
Japan
Prior art keywords
icam
ticam
multimeric
group
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6502541A
Other languages
English (en)
Japanese (ja)
Inventor
グリーブ，ジエフリー・エム
マクルランド，アラン
Original Assignee
マイルス・インコーポレーテツド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by マイルス・インコーポレーテツド filed Critical マイルス・インコーポレーテツド
Publication of JPH06510208A publication Critical patent/JPH06510208A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/085—Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
    • C07K14/095—Rhinovirus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/08—Peptides being immobilised on, or in, an organic carrier the carrier being a synthetic polymer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP6502541A 1992-06-22 1993-06-22 多量体形態のヒトライノウイルスレセプタ蛋白質 Pending JPH06510208A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90306992A 1992-06-22 1992-06-22
US903,069 1992-06-22
PCT/US1993/005972 WO1994000485A1 (en) 1992-06-22 1993-06-22 Multimeric forms of human rhinovirus receptor protein

Publications (1)

Publication Number Publication Date
JPH06510208A true JPH06510208A (ja) 1994-11-17

Family

ID=25416893

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6502541A Pending JPH06510208A (ja) 1992-06-22 1993-06-22 多量体形態のヒトライノウイルスレセプタ蛋白質

Country Status (10)

Country Link
EP (1) EP0604624A4 (de)
JP (1) JPH06510208A (de)
KR (1) KR950702576A (de)
AU (1) AU675441B2 (de)
CA (1) CA2116109A1 (de)
FI (1) FI946006A0 (de)
HU (1) HUT75827A (de)
NO (1) NO944966L (de)
RU (1) RU94046450A (de)
WO (1) WO1994000485A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2141076T3 (es) 1988-09-01 2000-03-16 Bayer Ag Proteina del receptor de rinovirus humano que inhibe la infectividad del virus.
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
GB9414966D0 (en) * 1994-07-26 1994-09-14 Danbiosyst Uk Pharmaceutical compositions for the nasal administration of antiviral agents
GB9520641D0 (en) * 1995-10-10 1995-12-13 Medical Res Council Improvements in or relating to protection against intracellular infection
US6391452B1 (en) 1997-07-18 2002-05-21 Bayer Corporation Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
JP6431476B2 (ja) * 2012-03-31 2018-11-28 アール−ファーム・インターナショナル・リミテッド・ライアビリティ・カンパニーＲ−Ｐｈａｒｍ Ｉｎｔｅｒｎａｔｉｏｎａｌ， Ｌｌｃ オステオプロテゲリン由来の組成物およびその使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68929477T2 (de) * 1988-09-28 2004-06-03 Dana-Farber Cancer Institute, Boston Interzellulare Adhäsions-Moleküle und deren Bindungsliganden
DK0387701T3 (da) * 1989-03-09 1992-12-07 Boehringer Ingelheim Pharma Anvendelse af intercellulære adhæsionsmolekyler samt deres bindende ligander ved behandling af astma
ES2134762T3 (es) * 1990-07-20 1999-10-16 Bayer Ag Formas multimericas de proteinas receptoras de rinovirus humanos.

Also Published As

Publication number Publication date
AU675441B2 (en) 1997-02-06
EP0604624A1 (de) 1994-07-06
KR950702576A (ko) 1995-07-29
FI946006L (fi) 1994-12-21
WO1994000485A1 (en) 1994-01-06
HU9403720D0 (en) 1995-02-28
RU94046450A (ru) 1996-10-10
EP0604624A4 (de) 1997-03-12
FI946006A7 (fi) 1994-12-21
AU4543293A (en) 1994-01-24
NO944966D0 (no) 1994-12-21
HUT75827A (en) 1997-05-28
NO944966L (no) 1994-12-21
FI946006A0 (fi) 1994-12-21
CA2116109A1 (en) 1994-01-06

Similar Documents

Publication Publication Date Title
KR100208847B1 (ko) 인간 리노바이러스 수용체 단백질의 다중형
JP3560344B2 (ja) プロトカドヘリンタンパク質およびその使用
JP3520272B2 (ja) リンパ球機能関連抗原３のｃｄ２結合ドメイン
EP0510079B1 (de) Durch menschliche lymphozyten produzierte proteine, die für diese proteine kodierende dns und pharmazeutische und biologische verwendungen
JP3253064B2 (ja) ウイルスの感染性を阻止するヒトライノウイルス受容体タンパク質
EP0391088B1 (de) Verwendung von funkionellen Derivaten des Interzellulär-Adhäsions-Moleküls ICAM-1 in einer Antivirus-Therapie
JP2009183303A (ja) Ｉｃａｍ−１に対するヒト化抗体、それらの生成および使用
AU689078B2 (en) Glucagon receptors
JP2005503147A (ja) ウイルスコートタンパク質／受容体キメラおよび使用方法
US5674982A (en) Multimeric form of human rhinovirus receptor protein
US5871733A (en) Multimeric forms of human rhinovirus receptor protein
EP1514932A2 (de) Glucagonrezeptoren
US6326004B1 (en) Antiviral methods using fragments of human rhinovirus receptor (ICAM-1)
NZ239518A (en) Human zona pellucida protein-3, (zp3), fragments, recombinant products and immunocontraceptive vaccine
US7074411B1 (en) α-β C4BP-type recombinant heteromultimeric proteins
US5773293A (en) Anti-ICAM-4 antibodies and hybridomas
AU675441B2 (en) Multimeric forms of human rhinovirus receptor protein
US6107461A (en) Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
PL188612B1 (pl) Oczyszczony i wyizolowany DNA, chimeryczny polinukleotyd, wektor ekspresyjny i komórka gospodarza transformowana tym wektorem
WO1995004756A1 (en) Complement inhibitor proteins of non-human primates
US5852170A (en) ICAM-4 materials and methods
AU710965B2 (en) Multimeric forms of human rhinovirus receptor protein
CA2205881A1 (en) Tcr scfv and biological applications thereof
Strosberg Molecular Biology of β2-Adrenergic Receptors
HK1003104B (en) Use of functional derivatives of the intercellular adhesion molecule icam-1 in anti-viral therapy

Legal Events

Date Code Title Description
A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20040204

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20040322

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20040817